Literature DB >> 6817933

Viral hepatitis.

F Deinhardt, I D Gust.   

Abstract

THREE FORMS OF VIRAL HEPATITIS CAN BE RECOGNIZED: hepatitis A, hepatitis B, and hepatitis non-A, non-B. Hepatitis A is caused by a picornavirus, is transmitted by the faceal-oral route, does not become chronic, and no chronic virus carriers exist. The virus can be grown in cell cultures, and killed as well as live attenuated virus vaccines are under development. Hepatitis B is caused by an enveloped virus containing a circular, double-stranded form of DNA. The disease is transmitted parenterally through inoculation of blood or blood products containing virus or through close personal contact with a virus-positive person. Hepatitis B becomes chronic in a certain number of cases and can lead to cirrhosis and primary liver cell carcinoma. The blood and certain body secretions of individuals with a persistent or chronic infection may remain infectious for many years. The hepatitis B virus cannot be grown in cell cultures but the entire genome has been sequenced and cloned in bacterial and eukaryotic cells. An inactivated virus vaccine has been prepared from hepatitis B surface antigen present in the plasma of hepatitis B virus carriers and further vaccines are under development. The agents of hepatitis non-A, non-B have not been identified. It is possible to distinguish between a predominantly parenterally transmitted and an orally transmitted form of hepatitis non-A, non-B. The latter is reported to be caused by a picornavirus that does not, however, have any antigenic relationship with hepatitis A virus.

Entities:  

Mesh:

Year:  1982        PMID: 6817933      PMCID: PMC2536038     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  6 in total

1.  Chemically synthesized peptides predicted from the nucleotide sequence of the hepatitis B virus genome elicit antibodies reactive with the native envelope protein of Dane particles.

Authors:  R A Lerner; N Green; H Alexander; F T Liu; J G Sutcliffe; T M Shinnick
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

2.  Antibody to hepatitis B surface antigen after a single inoculation of uncoupled synthetic HBsAg peptides.

Authors:  G R Dreesman; Y Sanchez; I Ionescu-Matiu; J T Sparrow; H R Six; D L Peterson; F B Hollinger; J L Melnick
Journal:  Nature       Date:  1982-01-14       Impact factor: 49.962

3.  A synthetic peptide with hepatitis B surface antigen reactivity.

Authors:  T P Hopp
Journal:  Mol Immunol       Date:  1981-09       Impact factor: 4.407

4.  Hepatitis B virus vaccine: identification of HBsAg/a and HBsAg/d but not HBsAg/y subtype antigenic determinants on a synthetic immunogenic peptide.

Authors:  A M Prince; H Ikram; T P Hopp
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

5.  Epidemic and endemic hepatitis in India: evidence for a non-A, non-B hepatitis virus aetiology.

Authors:  D C Wong; R H Purcell; M A Sreenivasan; S R Prasad; K M Pavri
Journal:  Lancet       Date:  1980-10-25       Impact factor: 79.321

6.  Study of an epidemic of non-A, non-B hepatitis. Possibility of another human hepatitis virus distinct from post-transfusion non-A, non-B type.

Authors:  M S Khuroo
Journal:  Am J Med       Date:  1980-06       Impact factor: 4.965

  6 in total
  10 in total

1.  Isolation and molecular cloning of a fast-growing strain of human hepatitis A virus from its double-stranded replicative form.

Authors:  A Venuti; C Di Russo; N del Grosso; A M Patti; F Ruggeri; P R De Stasio; M G Martiniello; P Pagnotti; A M Degener; M Midulla
Journal:  J Virol       Date:  1985-11       Impact factor: 5.103

2.  A sero-epidemiologic study of a water-borne epidemic of viral hepatitis in Kolhapur City, India.

Authors:  M A Sreenivasan; A Sehgal; S R Prasad; S Dhorje
Journal:  J Hyg (Lond)       Date:  1984-08

3.  In situ detection of hepatitis A virus in cell cultures and shellfish tissues.

Authors:  J L Romalde; M K Estes; G Szücs; R L Atmar; C M Woodley; T G Metcalf
Journal:  Appl Environ Microbiol       Date:  1994-06       Impact factor: 4.792

4.  Prevalence of hepatitis virus infections in Albanian refugees.

Authors:  T Santantonio; S Lo Caputo; C Germinario; S Squarcione; D Greco; V Laddago; G Pastore
Journal:  Eur J Epidemiol       Date:  1993-09       Impact factor: 8.082

5.  Hepatitis B virus antibody prevalence in anaesthetists.

Authors:  M A Chernesky; R A Browne; P Rondi
Journal:  Can Anaesth Soc J       Date:  1984-05

6.  The etiology of acute hepatitis in hospitalized children in Cairo Egypt.

Authors:  S Zakaria; R S Goldsmith; M S Zakaria; M A Kamel; E H el-Raziky
Journal:  Infection       Date:  1988 Sep-Oct       Impact factor: 3.553

7.  Oncological consequences of impaired immune surveillance against ubiquitous viruses.

Authors:  D T Purtilo; J Linder
Journal:  J Clin Immunol       Date:  1983-07       Impact factor: 8.317

8.  Seroprevalence of Hepatitis B Surface Antigen and Occupational Risk Factors Among Health Care Workers in Ekiti State, Nigeria.

Authors:  Oluwole Ojo Alese; Margaret Olutayo Alese; Afolabi Ohunakin; Peter Olumuyiwa Oluyide
Journal:  J Clin Diagn Res       Date:  2016-02-01

9.  Nursery-associated hepatitis A traced to a male nurse.

Authors:  I Ebisawa; Y Kurosu; T Hatashita
Journal:  J Hyg (Lond)       Date:  1984-04

10.  Breast-feeding and breast cancer in the offspring.

Authors:  A Ekbom; C C Hsieh; D Trichopoulos; Y Y Yen; E Petridou; H O Adami
Journal:  Br J Cancer       Date:  1993-04       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.